Effective January 18, 2024, DSS, Inc. and Impact BioMedical, Inc., entered into an amendment to the revolving promissory note dated March 1, 2023, whereby the Company loaned Impact an original amount of up to $12,000,000. Pursuant to the amendment, the Company has agreed to amend the existing Original Note to extend the maturity date of the Loan to September 30, 2030, advance funds under the Original Note to fund and pay interest to date, bringing the funded principal balance to $12,859,328.60, eliminate any advance feature under the terms of the Original Note, establish specific repayment terms for the Note balance, and amend the interest rate to a market rate of interest. The Amendment is secured by a blanket first lien on all assets of Impact including but not limited to, any licenses or patents owned.

Pursuant to the Amendment, payment of interest and principal will be on demand. If the Company does not make a demand, then Impact will repay the principal and interest in 60 payments on the last day of each month during the period from February 1, 2024, through and including January 31, 2026, Impact will pay the Company the outstanding unpaid accrued interest owing; on the last day of each month during the period from February 1, 2026, through and including August 31, 2030, Impact will pay the Company $126,380.80, being comprised of both principal and interest payment; and on September 30, 2030, Impact will pay the entire amount of unpaid principal and interest then outstanding. The Amendment to the Original Note has modified the interest rate to WSJ Prime + 0.50% floating daily, with an initial interest rate of 9% and the post maturity rate is the lesser of the maximum rate allowed by law or 18.000% per annum based on a year of 360 days.

Impact may pay without penalty all or a portion of the amount owed earlier than it is due. If an event of default occurs, other than a default in payment under the Amendment or any other note and/or the filing of bankruptcy, whether voluntarily or involuntarily, is curable, it may be cured if Impact, after the Company sends written notice demanding cure of such default, cures the default within ten business days; or if the cure requires more than ten business days, immediately initiates steps which the Company deems its sole discretion to be sufficient to cure the default and thereafter continues and completes all reasonable and necessary steps sufficient to produce compliance as soon as reasonably practical. Impact has agreed to indemnify the Company and, among others, its members, officers and directors from and against any and all losses, damages, expenses or liabilities of any kind or nature and from any suits, claims or demands incurred in investigating or defending such claim, suffered by any of them and caused by, relating to, arising out of, resulting from, or in any way connected with the note, any loan documents or the transactions contemplated therein.